China Jo-Jo Drugstores Enters Share Purchase Agreement

Ticker: RDGT · Form: 6-K · Filed: Jun 11, 2024 · CIK: 1856084

China Jo-Jo Drugstores, Inc. 6-K Filing Summary
FieldDetail
CompanyChina Jo-Jo Drugstores, Inc. (RDGT)
Form Type6-K
Filed DateJun 11, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.24, $1.70, $3,366,000, $3,316,000
Sentimentneutral

Sentiment: neutral

Topics: share-purchase, agreement, foreign-private-issuer

TL;DR

Jo-Jo Drugstores signed a share deal on June 11th, details TBD.

AI Summary

On June 11, 2024, China Jo-Jo Drugstores, Inc. entered into a Share Purchase Agreement. The filing does not disclose the specific counterparty or the dollar amount of the transaction, but it is being reported on Form 6-K, indicating it's a report of a foreign private issuer.

Why It Matters

This filing signals a potential change in the company's share structure or ownership, which could impact its market position and investor relations.

Risk Assessment

Risk Level: medium — The lack of specific details regarding the share purchase agreement introduces uncertainty about the transaction's implications.

Key Players & Entities

  • China Jo-Jo Drugstores, Inc. (company) — Registrant
  • June 11, 2024 (date) — Date of Share Purchase Agreement

FAQ

What is the nature of the Share Purchase Agreement entered into by China Jo-Jo Drugstores, Inc. on June 11, 2024?

The filing states that on June 11, 2024, the Company entered into certain Share Purchase Agreement, but does not provide further details within the provided text.

Who is the counterparty to the Share Purchase Agreement?

The provided text does not specify the counterparty to the Share Purchase Agreement.

What is the financial value or size of the Share Purchase Agreement?

The filing does not disclose the dollar amount or size of the Share Purchase Agreement.

What is the principal executive office address of China Jo-Jo Drugstores, Inc.?

The principal executive offices are located at 4th Floor, Building 5, Renxin Yaju, Gong Shu District, Hangzhou City, Zhejiang Province, People's Republic of China, 310014.

Is China Jo-Jo Drugstores, Inc. required to file annual reports under Form 20-F or Form 40-F?

China Jo-Jo Drugstores, Inc. is required to file annual reports under cover of Form 20-F.

Filing Stats: 481 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2024-06-11 09:00:03

Key Financial Figures

  • $0.24 — s (the “Shares”), par value $0.24 per share, of the Company (“Ordin
  • $1.70 — Shares”), at a purchase price of $1.70 per Share (the “Purchase Price&rd
  • $3,366,000 — regate gross proceeds to the Company of $3,366,000. Net proceeds to the Company from the
  • $3,316,000 — enses, are expected to be approximately $3,316,000. The Offering is expected to close on o

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: June 11, 2024 CHINA JO-JO DRUGSTORES, INC. By: /s/ Lei Liu Name: Lei Liu Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.